ConductScience.org, home

Trial · NCT04804358

Registered outcomes21

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChanges in high frequency heart variability (HF-HRV) across the exposition test (before, during and after)inclusion visitWe aim to investigate if AM-T patients present changes in HF-HRV across exposition test compared to AM-C patients, measured by Biopac MP160
SecondaryChanges in low frequency heart variability (LF-HRV) across the exposition test (before, during and after)inclusion visitWe aim to investigate if AM-T patients present changes in LF-HRV across exposition test compared to AM-C patients, measured by Biopac MP160
SecondaryChanges in very low frequency heart variability (VLF-HRV) across the exposition test (before, during and after)inclusion visitWe aim to investigate if AM-T patients present changes in VLF-HRV across exposition test compared to AM-C patients, measured by Biopac MP160
SecondaryChanges in the highest peak of the high frequency (HFhz) across the exposition test (before, during and after)inclusion visitWe aim to investigate if AM-T patients present changes in HFhz across exposition test compared to AM-C patients, measured by Biopac MP160
SecondaryChanges in the interval between R peaks (R-R across the exposition test (before, during and after)inclusion visitWe aim to investigate if AM-T patients present R-R changes across exposition test compared to AM-C patients, measured by Biopac MP160
SecondaryChanges in the R-R interval standard difference (STD-RR) across the exposition test (before, during and after)inclusion visitWe aim to investigate if AM-T patients present STD-RR changes across exposition test compared to AM-C patients, measured by Biopac MP160
SecondaryChanges in the root mean successive squared differences of the R-R interval (RMSSD). across the exposition test (before, during and after)inclusion visitWe aim to investigate if AM-T patients present RMSSD changes across exposition test compared to AM-C patients, measured by Biopac MP160
SecondaryScore to the Difficulties in Emotion Regulation Scaleinclusion visit
We aim to assess the link between emotional regulation and psychological trauma in AN. DERS is a self-assessment scale measuring emotion dysregulation. The original DERS includes 36 items scored 1-5 where 1 is almost never, 2 is sometimes, 3 is about half the time, 4 is most of the time, and 5 is almost always. Of the 36 items, 11 are reverse scored. The DERS-36 yields a total score as well as six subscales where higher scores indicate more difficulties.
SecondaryScore to the Beck depression inventory IIinclusion visit
We aim to assess the link between eating symptomatology and psychological trauma in AN. The BDI-II is a self-administered questionnaire assessing the severity of depressive symptoms in 21 items. Each item is rated on a 4-points Likert scale ranging from 0 to 3. The total score varies between 0 and 63. higher scores mean more depressive symptoms
SecondaryScore to the Eating Disorder Questionnaireinclusion visit
We aim to assess the link betxeen eating symptomatology and psychological trauma in AN. self-administered questionnaire assessing the intensity of eating symptoms over the past 28 days. A total score as well as 4 sub-scores (restriction, diet, weight, shape) varying from 0 to 6 are obtained.Higher scores mean higher eating concerns
SecondaryScore to the Eating Disorder Inventoryinclusion visit
We aim to assess the link between eating symptomatology and psychological trauma in AN. The EDI-2 is a 91-item self-report questionnaire assessing cognitive, emotional, and behavioral symptoms of eating disorders. It rates from 0 to 273. Higher scores means severe symptoms
SecondaryScore to the Childhood trauma questionnaireinclusion visit
SecondaryScore to the PTSD Checklist for DSM-5inclusion visit
SecondaryScore to the Wisconson Card Sorting Testinclusion visitWe aim to assess the link between mental flexibility, working memory, inhibition and psychological trauma in AN
SecondaryScore to the Stroop Testinclusion visitWe aim to assess the link between mental flexibility, working memory, inhibition and psychological trauma in AN
SecondaryScore to the Delay Discounting Testinclusion visitWe aim to assess the link between decision making and psychological trauma in AN
SecondaryScore to the Trail Making Testinclusion visitWe aim to assess the link between mental flexibility, visio-spatial attention, processing speed and psychological trauma in AN
SecondaryChanges in salivary tryptophaninclusion visitstudy changes in salivary tryptophan before and after exposition test
SecondaryChanges in salivary kynurenineinclusion visitstudy changes in salivary kynurenine before and after exposition test
SecondaryChanges in salivary P substanceinclusion visitstudy changes in salivary P substance before and after exposition test

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT04804358/registered